Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial
Sibonakaliso Vilakati, Nontokozo Mngadi, Jade Benjamin-Chung, Nomcebo Dlamini, Mi-Suk Kang Dufour, Brooke Whittemore, Khayelihle Bhangu, Lisa M. Prach, Kimberly Baltzell, Nomcebo Nhlabathi, Calisile Malambe, Bongani Dlamini, Danica Helb, Bryan Greenhouse, Gugu Maphalala, Deepa Pindolia, Muhindo Kalungero, Getahun Tesfa, Roly Gosling, Nyasatu Ntshalintshali, Simon Kunene, Michelle S. Hsiang
doi: https://doi.org/10.1101/2021.03.12.21252721
Sibonakaliso Vilakati
1Eswatini National Malaria Program, Manzini, Eswatini
Nontokozo Mngadi
2Clinton Health Access Initiative, Mbabane, Eswatini
Jade Benjamin-Chung
3Division of Epidemiology & Biostatistics, University of California, Berkeley, USA
4Malaria Elimination Initiative, Global Health Group, UCSF
Nomcebo Dlamini
1Eswatini National Malaria Program, Manzini, Eswatini
Mi-Suk Kang Dufour
3Division of Epidemiology & Biostatistics, University of California, Berkeley, USA
5Department of Medicine, University of California, San Francisco (UCSF), USA
Brooke Whittemore
6Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA
Khayelihle Bhangu
1Eswatini National Malaria Program, Manzini, Eswatini
Lisa M. Prach
4Malaria Elimination Initiative, Global Health Group, UCSF
Kimberly Baltzell
7Department of Family Health Care Nursing, UCSF
Nomcebo Nhlabathi
1Eswatini National Malaria Program, Manzini, Eswatini
Calisile Malambe
1Eswatini National Malaria Program, Manzini, Eswatini
Bongani Dlamini
2Clinton Health Access Initiative, Mbabane, Eswatini
Danica Helb
5Department of Medicine, University of California, San Francisco (UCSF), USA
Bryan Greenhouse
5Department of Medicine, University of California, San Francisco (UCSF), USA
Gugu Maphalala
8Department of Medicine National Clinical Laboratory Services, Mbabane, Eswatini
Deepa Pindolia
2Clinton Health Access Initiative, Mbabane, Eswatini
Muhindo Kalungero
9Good Shepherd Hospital, Siteki, Eswatini
Getahun Tesfa
10Raleigh Fitkin Memorial Hospital, Manzini, Eswatini
Roly Gosling
4Malaria Elimination Initiative, Global Health Group, UCSF
Nyasatu Ntshalintshali
2Clinton Health Access Initiative, Mbabane, Eswatini
Simon Kunene
1Eswatini National Malaria Program, Manzini, Eswatini
Michelle S. Hsiang
4Malaria Elimination Initiative, Global Health Group, UCSF
6Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA
11Department of Pediatrics, UCSF
Data Availability
The data that support the findings of this study are available from Eswatini Ministry of Health but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Eswatini Ministry of Health.
Posted March 12, 2021.
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial
Sibonakaliso Vilakati, Nontokozo Mngadi, Jade Benjamin-Chung, Nomcebo Dlamini, Mi-Suk Kang Dufour, Brooke Whittemore, Khayelihle Bhangu, Lisa M. Prach, Kimberly Baltzell, Nomcebo Nhlabathi, Calisile Malambe, Bongani Dlamini, Danica Helb, Bryan Greenhouse, Gugu Maphalala, Deepa Pindolia, Muhindo Kalungero, Getahun Tesfa, Roly Gosling, Nyasatu Ntshalintshali, Simon Kunene, Michelle S. Hsiang
medRxiv 2021.03.12.21252721; doi: https://doi.org/10.1101/2021.03.12.21252721
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial
Sibonakaliso Vilakati, Nontokozo Mngadi, Jade Benjamin-Chung, Nomcebo Dlamini, Mi-Suk Kang Dufour, Brooke Whittemore, Khayelihle Bhangu, Lisa M. Prach, Kimberly Baltzell, Nomcebo Nhlabathi, Calisile Malambe, Bongani Dlamini, Danica Helb, Bryan Greenhouse, Gugu Maphalala, Deepa Pindolia, Muhindo Kalungero, Getahun Tesfa, Roly Gosling, Nyasatu Ntshalintshali, Simon Kunene, Michelle S. Hsiang
medRxiv 2021.03.12.21252721; doi: https://doi.org/10.1101/2021.03.12.21252721
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (206)
- Cardiovascular Medicine (2968)
- Dermatology (252)
- Emergency Medicine (445)
- Epidemiology (12803)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4617)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2941)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (932)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (475)
- Neurology (4403)
- Nursing (238)
- Nutrition (648)
- Oncology (2292)
- Ophthalmology (651)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (280)
- Palliative Medicine (84)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6996)
- Radiology and Imaging (1542)
- Respiratory Medicine (920)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)